BCL-2 is dispensable for thrombopoiesis and platelet survival
MA Debrincat, I Pleines, M Lebois, RM Lane, ML Holmes, J Corbin, CJ Vandenberg, WS Alexander, AP Ng, A Strasser, P Bouillet, M Sola-Visner, BT Kile, EC Josefsson
Cell Death & Disease | NATURE PUBLISHING GROUP | Published : 2015
Awarded by Australian National Health and Medical Research Council
Awarded by Independent Research Institutes Infrastructure Support Scheme Grant from the Australian National Health and Medical Research Council
Awarded by German Research Foundation (DFG)
Awarded by Leukemia and Lymphoma Society Specialized Center of Research Grant
We thank M. Carpinelli, S. Grabow, J. McManus, S. Green, K. Franks, E. Simankowicz, K. Stoev, M. Do and L. Wilkins for outstanding assistance; and J. Zhang, D. Segal and M. Van Delft for methodological advice. This work was supported by Project Grants (575535, 1079250, 1060179), Program Grants (1016647, 1016701), Fellowships (BTK 1063008, WSA 1058344, AS 1020363) and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council; a fellowship from the Sylvia and Charles Viertel Foundation (BTK); a fellowship from the German Research Foundation (IP DFG, PL707/1-1); the Australian Cancer Research Fund, the Science and Industry Endowment Fund; the Sir Edward Dunlop Medical Research Foundation Grant (APN), the Leukemia and Lymphoma Society Specialized Center of Research Grant (7001-13) and a Victorian State Government Operational Infrastructure Support Grant.